Search
News
Downloads
About
Help
Contact
Entity Details
Primary name
LPAR2_HUMAN
Entity type
UniProt
Source
Source Link
Details
Accession
Q9HBW0
EntryName
LPAR2_HUMAN
FullName
Lysophosphatidic acid receptor 2
TaxID
9606
Evidence
evidence at protein level
Length
351
SequenceStatus
complete
DateCreated
2002-12-06
DateModified
2021-06-02
Ontological Relatives
Genes
LPAR2
GO terms
Show/Hide Table
GO
Name
GO:0004930
G protein-coupled receptor activity
GO:0005737
cytoplasm
GO:0005886
plasma membrane
GO:0005887
integral component of plasma membrane
GO:0007186
G protein-coupled receptor signaling pathway
GO:0007189
adenylate cyclase-activating G protein-coupled receptor signaling pathway
GO:0007202
activation of phospholipase C activity
GO:0007204
positive regulation of cytosolic calcium ion concentration
GO:0008289
lipid binding
GO:0009986
cell surface
GO:0019222
regulation of metabolic process
GO:0070915
lysophosphatidic acid receptor activity
Subcellular Location
Show/Hide Table
Subcellular Location
Cell membrane
Cell surface
Domains
Show/Hide Table
Domain
Name
Category
Type
IPR000276
G protein-coupled receptor, rhodopsin-like
Family
Family
IPR004065
Lysophosphatidic acid receptor
Family
Family
IPR004066
Lysophosphatidic acid receptor EDG-4
Family
Family
IPR017452
GPCR, rhodopsin-like, 7TM
Domain
Domain
Diseases
Show/Hide Table
Drugs
Show/Hide Table
Interactions
10 interactions
Interactor
Partner
Sources
Publications
Link
LPAR2_HUMAN
NHRF2_HUMAN
BioGRID, HPRD, IntAct
15143197
16203867
19293149
details
LPAR2_HUMAN
ATX1_HUMAN
BioGRID, IntAct
23275563
details
LPAR2_HUMAN
TRIP6_HUMAN
BioGRID, HPRD
14688263
16624523
19293149
details
LPAR2_HUMAN
SIVA_HUMAN
BioGRID
19293149
details
LPAR2_HUMAN
PLCB3_HUMAN
BioGRID
15143197
details
LPAR2_HUMAN
GIPC1_HUMAN
BioGRID
23145131
details
LPAR2_HUMAN
CFTR_HUMAN
IntAct
16203867
details
LPAR2_HUMAN
ARHGB_HUMAN
HPRD
15755723
details
LPAR2_HUMAN
ARHGC_HUMAN
HPRD
15755723
details
LPAR2_HUMAN
NHRF1_HUMAN
HPRD
16203867
details
This website requires cookies in order to function. By using the site you are agreeing to this as outlined in our
Terms of Use
I Agree